Article Text

Download PDFPDF

Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke
  1. Adam de Havenon1,
  2. Alicia Bennett2,
  3. Gregory J Stoddard2,
  4. Gordon Smith2,
  5. Lee Chung2,
  6. Steve O'Donnell2,
  7. J Scott McNally2,
  8. David Tirschwell3,
  9. Jennifer J Majersik2
  1. 1Department of Neurology, University of Utah, Salt Lake City, Utah, USA
  2. 2University of Utah, Salt Lake City, Utah, USA
  3. 3University of Washington, Seattle, Washington, USA
  1. Correspondence to Dr Adam de Havenon; adam.dehavenon{at}hsc.utah.edu

Abstract

Introduction Increased blood pressure variability (BPV) is detrimental after acute ischaemic stroke, but the interaction between BPV and neuroimaging factors that directly influence stroke outcome has not been explored.

Methods We retrospectively reviewed inpatients from 2007 to 2014 with acute anterior circulation ischaemic stroke, CT perfusion and angiography at hospital admission, and a modified Rankin Scale (mRS) 30–365 days after stroke onset. BPV indices included SD, coefficient of variation and successive variation of the systolic blood pressure between 0 and 120 hours after admission. Ordinal logistic regression models were fitted to mRS with predictor variables of BPV indices. Models were further stratified by CT perfusion volumetric measurements, proximal vessel occlusion and collateral score.

Results 110 patients met the inclusion criteria. The likelihood of a 1-point rise in the mRS increased with every 10 mm Hg increase in BPV (OR for the 3 BPV indices ranged from 2.27 to 5.54), which was more pronounced in patients with larger ischaemic core volumes (OR 8.37 to 18.0) and larger hypoperfused volumes (OR 6.02 to 15.4). This association also held true for patients with larger mismatch volume, proximal vessel occlusion and good collateral vessels.

Conclusions These results indicate that increased BPV is associated with worse neurological outcome after stroke, particularly in patients with a large lesion core volume, concurrent viable ischaemic penumbra, proximal vessel occlusion and good collaterals. This subset of patients, who are often not candidates for or fail acute stroke therapies such as intravenous tissue plasminogen activator or endovascular thrombectomy, may benefit from interventions aimed at reducing BPV.

  • Blood Pressure
  • CT perfusion
  • Stroke

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AdH conceived of the study, reviewed all data, performed statistical analysis, and drafted and edited the manuscript. GJS assisted with statistical analysis. AB, LC and SO reviewed patient charts and performed assessment of imaging end points. JSM performed imaging assessment and edited the manuscript. JMM helped conceive the study, draft and edit the manuscript. GS and DT helped conceive the study and edit the manuscript.

  • Funding Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number KL2TR001065.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  • Competing interests None declared.

  • Ethics approval The study was approved by the local Institutional Review Board and is retrospective research that did not involve a medical or surgical intervention.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.